Literature DB >> 18381578

Serum ghrelin levels are increased in hypothyroid patients and become normalized by L-thyroxine treatment.

Signe Gjedde1, Esben Thyssen Vestergaard, Lars Christian Gormsen, Anne Lene Dalkjaer Riis, Jørgen Rungby, Niels Møller, Jørgen Weeke, Jens Otto Lunde Jørgensen.   

Abstract

CONTEXT: An interaction between ghrelin, which is implicated in the regulation of short- and long-term energy balance, and thyroid function has been reported in hyperthyroidism in which ghrelin levels are reversibly suppressed. We measured serum ghrelin levels and metabolic indices in hypothyroid patients before and after L-thyroxine replacement. PATIENTS AND METHODS: Eleven patients were examined twice: 1) in the hypothyroid state and 2) after at least 2 months of euthyroidism. Ten healthy subjects served as a control group. Ghrelin was measured in conjunction with indirect calorimetry and a hyperinsulinemic euglycemic clamp.
RESULTS: Serum ghrelin levels were increased by 32% under basal conditions in the hypothyroid state (PRE) as compared with posttreatment (POST) (picograms per milliliter): 976.4 +/- 80.8 vs. 736.8 +/- 67.1 (P < 0.001). This difference prevailed during the clamp, but a decline was observed in both states: 641.4 +/- 82.2 vs. 444.3 +/- 66.8 microg/ml (P = 0.005). The hypothyroid state was associated with decreased resting energy expenditure, increased respiratory quotient, and insulin resistance. Serum ghrelin levels as well as the metabolic aberrations became normalized after L-thyroxine replacement as compared with the control subjects.
CONCLUSION: Serum ghrelin levels are reversibly increased in hypothyroid patients. It remains to be investigated whether this represents a direct effect of iodothyronines on ghrelin secretion or clearance or a compensatory response to the abnormal energy metabolism in hypothyroid patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18381578     DOI: 10.1210/jc.2007-2619

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

Review 1.  Interrelationships between ghrelin, insulin and glucose homeostasis: Physiological relevance.

Authors:  François Chabot; Alexandre Caron; Mathieu Laplante; David H St-Pierre
Journal:  World J Diabetes       Date:  2014-06-15

2.  Expression of obestatin and ghrelin in papillary thyroid carcinoma.

Authors:  Aziz Karaoglu; Suleyman Aydin; Adile F Dagli; David E Cummings; Ibrahim H Ozercan; Halit Canatan; Yusuf Ozkan
Journal:  Mol Cell Biochem       Date:  2008-11-28       Impact factor: 3.396

3.  Plasma total and acylated Ghrelin concentrations in patients with clinical and subclinical thyroid dysfunction.

Authors:  M L Tanda; V Lombardi; M Genovesi; F Ultimieri; A Lai; M Gandolfo; I Dalle Mule; L Grasso; F Bogazzi; F Broglio; E Ghigo; E Martino; L Bartalena
Journal:  J Endocrinol Invest       Date:  2009-01       Impact factor: 4.256

4.  Effects of Acute Recombinant Human TSH on Serum Ghrelin Levels.

Authors:  Cristina Ciuoli; Lucia Brusco; Alexandra Theodoropoulou; Maria Grazia Castagna; Ornella Neri; Letizia Pasqui; Furio Pacini
Journal:  Front Endocrinol (Lausanne)       Date:  2011-12-16       Impact factor: 5.555

5.  Thyroid disorders and diabetes mellitus.

Authors:  Mirella Hage; Mira S Zantout; Sami T Azar
Journal:  J Thyroid Res       Date:  2011-07-12

6.  Serum Concentrations of Ghrelin and Leptin according to Thyroid Hormone Condition, and Their Correlations with Insulin Resistance.

Authors:  Kyu Jin Kim; Bo Yeon Kim; Ji Oh Mok; Chul Hee Kim; Sung Koo Kang; Chan Hee Jung
Journal:  Endocrinol Metab (Seoul)       Date:  2015-05-18

7.  Ghrelin-mediated inhibition of the TSH-stimulated function of differentiated human thyrocytes ex vivo.

Authors:  Maria Barington; Marianne Møller Brorson; Jacob Hofman-Bang; Åse Krogh Rasmussen; Birgitte Holst; Ulla Feldt-Rasmussen
Journal:  PLoS One       Date:  2017-09-20       Impact factor: 3.240

8.  Inadequate control of thyroid hormones sensitizes to hepatocarcinogenesis and unhealthy aging.

Authors:  Livia López-Noriega; Vivian Capilla-González; Nadia Cobo-Vuilleumier; Eugenia Martin-Vazquez; Petra Isabel Lorenzo; Enrique Martinez-Force; Mario Soriano-Navarro; María García-Fernández; Silvana Yanina Romero-Zerbo; Francisco Javier Bermúdez-Silva; Irene Díaz-Contreras; Ana Sánchez-Cuesta; Carlos Santos-Ocaña; Abdelkrim Hmadcha; Bernat Soria; Franz Martín; Benoit Raymond Gauthier; Alejandro Martin-Montalvo
Journal:  Aging (Albany NY)       Date:  2019-09-13       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.